Referens
7
I tidningen Biogenic Amines, G. Ali Qureshi
och medarbetare sammanfattade under »Future Clinical Implications«
»On the basis of future results on MS, the role of various neurotransmitters,
free radicals and metals, it may be possible to develop symptomatic
therapy with agonists or antagonists«
Qureshi, G.A., Halawa,A.Baig,S. and Sidén,Å., »Multiple
Sclerosis and neurotransmission«, Biogenic Amines 1996:12(5)
pp.353-376